retatrutide dosing trial Dosing: Early Clinical Insights on How It Might Work retatrutide dosing schedule clinical trial
Description
This paper is part of a Supplement that was financially supported by the ERA
Benefits of Retatrutide Therapy Unprecedented Weight Loss Early phase trials (NEJM 2023) showed average weight loss of ~24% at 48 weeks, which rivals bariatric surgery outcomes
Deletion of Nampt in projection neurons of adult mice leads to motor dysfunction, neurodegeneration, and death
Improved Insulin Sensitivity Boosts Ovulation For those with insulin resistance or PCOS , GLP-1 therapy helps regulate insulin levels, which can normalize ovulation and improve conception chances
